Cranberry Juice Capsules and Urinary Tract Infections

An NIH-funded clinical trial found that TheraCran reduced the rate of catheter-associated UTIs by 50% among women undergoing gynecologic surgery.
Conducted at the University of Michigan, the study randomized 160 women to either TheraCran or placebo for 6 weeks post op. The TheraCran group’s UTI rate was only 19% compared to 38% for the placebo group: a statistically significant 50% reduction.
The study will be published in an upcoming issue of the American Journal of Obstetrics and Gynecology. Click here to read the PubMed abstract.
Please contact your salesperson or the Nutrition Department (888 899 3899 x 4) with any questions or to receive a full reprint.
If you need more TheraCran HP samples and brochures for your office, please let us know.
Remember, the updated TheraCran HP is a high potency whole cranberry extract. Two daily capsules provide the recommended and studied dose of proanthocyanidins: 36 mg of PACs.

Learn More